CoV3D: A database and resource for high resolution coronavirus protein structures
R. Gowthaman, J. D. Guest, R. Yin, J. Adolf-Bryfogle, W. R. Schief, B. G. Pierce
Abstract
SARS-CoV-2, the etiologic agent behind COVID-19, exemplifies the general threat to global health posed by coronaviruses. The urgent need for effective vaccines and therapies is leading to a rapid rise in the number of high resolution structures of SARS-CoV-2 proteins that collectively reveal a map of virus vulnerabilities. To assist structure-based design of vaccines and therapeutics against SARS-CoV-2 and other coronaviruses, we have developed CoV3D, a database and resource for coronavirus protein structures, which is updated on a weekly basis. CoV3D provides users with comprehensive sets of structures of coronavirus proteins and their complexes with antibodies, receptors, and small molecules. Integrated molecular viewers allow users to visualize structures of the spike glycoprotein, which is the major target of neutralizing antibodies and vaccine design efforts, as well as sets of spike-antibody complexes, spike sequence variability, and known polymorphisms. In order to aid structure-based design and analysis of the spike glycoprotein, CoV3D permits visualization and download of spike structures with modeled N-glycosylation at known glycan sites, and contains structure-based classification of spike conformations, generated by unsupervised clustering. CoV3D can serve the research community as a centralized reference and resource for spike and other coronavirus protein structures, and is available at: https://cov3d.ibbr.umd.edu.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
M. G. Joyce, R. S. Sankhala, … K. Modjarrad·bioRxiv·Mar 15, 2020
- Closing coronavirus spike glycoproteins by structure-guided design
M. McCallum, A. C. Walls, … D. Veesler·bioRxiv·Jun 3, 2020
- CoV-AbDab: the Coronavirus Antibody Database
M. I. J. Raybould, A. Kovaltsuk, … C. M. Deane·bioRxiv·May 15, 2020
- Structure of nonstructural protein 1 from SARS-CoV-2.
L. K. Clark, T. J. Green, C. M. Petit·bioRxiv·Nov 3, 2020
- Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins
Y. Shi, J. Shi, … G. Peng·Journal of VirologyPeer-reviewed·Mar 10, 2021
- Tracking the opening of spike crowns on the surface of coronaviruses
Di Wu·bioRxiv·Nov 2, 2025